<DOC>
	<DOC>NCT00290849</DOC>
	<brief_summary>The objectives of this registry are to assess the use of the thrombin-specific anticoagulant bivalirudin during percutaneous coronary intervention (PCI) in a real life setting. In particular, data will be collected to analyze experiences of bivalirudin use in respect to the following objectives; - examine the aspects of safety and effectiveness of bivalirudin - gain experience regarding the characteristics of patients in bivalirudin treatment - evaluate the handling of bivalirudin and its practicality</brief_summary>
	<brief_title>ImproveR International (BI-001-IM)</brief_title>
	<detailed_description />
	<mesh_term>Bivalirudin</mesh_term>
	<criteria>&gt; 18 years, undergoing planned or urgent PCI with the intention to use bivalirudin as anticoagulant, written informed concent to entry of data information registry.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>